The hypothesis is that CLCN5 may cause FSGS and NS through regulation of podocyte trafficking, in addition to tubular dysfunction [151], so the effective molecular targets of CLCN5 have not yet been fully clarified. The gene discussed is CLCN5; the disease is focal segmental glomerulosclerosis.